Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Did CXR hit a home run with The purchase of AMCo?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by Scruggstyleon Mar 03, 2016 10:09pm
195 Views
Post# 24620445

Did CXR hit a home run with The purchase of AMCo?

Did CXR hit a home run with The purchase of AMCo?

Broad portfolio of more than 190 attractive, niche legacy products

Geographic diversification with global commercial reach and products marketed in more than 100 countries

Experienced management team plus Centre of Excellence in India

Flexible and asset-light business model complementary to Concordia strategy

Immediately accretive to earnings with more than 35% accretion expected in the first full year 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities